当前位置:首页 / 体外膜肺氧合对药物药代动力学的影响——现状、挑战与未来方向
| 更新时间:2024-11-27
|
体外膜肺氧合对药物药代动力学的影响——现状、挑战与未来方向
Effect of extracorporeal membrane oxygenation on drug pharmacokinetics: current status, challenges, and future directions

广西医学 页码:1468-1476

作者机构:韦永先,硕士,副主任医师,研究方向为急危重症临床救治。高汉铭为共同第一作者。

基金信息:广西重点研发计划项目(桂科AB22080088);广西自然科学基金面上项目(2023GXNSFAA026318);国家自然科学基金(82360372);广西医疗卫生重点学科建设项目;广西临床重点专科建设项目;广西医科大学一流学科创新驱动人才计划

DOI:10.11675/j.issn.0253⁃4304.2024.10.04

  • 中文简介
  • 英文简介
  • 参考文献

体外膜肺氧合 (ECMO) 作为一种重要的生命支持技术,在治疗危重症患者中发挥着关键作用。然而,ECMO 系统的复杂性对患者药物治疗的管理提出了挑战。本文总结ECMO如何通过药物的吸附、分布容积和清除率来影响不同类别药物的药代动力学特性。同时,本文还讨论在成人、儿童等不同患者群体中 ECMO治疗对药物药代动力学影响的差异,以及 ECMO 联合肾脏替代治疗对药物药代动力学的影响。此外,本文分析现有研究的局限性,并展望未来研究方向,以期为从事 ECMO 技术的医护人员提供参考,优化 ECMO 患者药物治疗的个体化管理。

Extracorporeal membrane oxygenation (ECMO), as an important life support technique, plays a critical role in the treatment of critically ill patients. However, the complexity of ECMO system poses a challenge on patients' pharmacotherapy. This paper summarizes how ECMO influences the pharmacokinetic properties of different categories of drugs through drug adsorption, volume of distribution, and clearance rate. Simultaneously, this paper also discusses the differences in effects of ECMO treatment on drug pharmacokinetics between different patient groups such as adults and children, as well as the effects of ECMO combined with renal replacement therapy on drug pharmacokinetics. In addition, this paper analyzes the limitations of existing research and look forward to the future research directions, aiming at providing references for medical and nursing personnel who are engaged in ECMO technique, and optimizing individualized management of ECMO patients' drug therapy.

273

浏览量

60

下载量

0

CSCD

工具集